- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00173693
What is the Best Policy to Prevent Osteoporotic Fracture?
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study aims to conduct a cost-effectiveness analysis (CEA) among the programs for preventing osteoporotic fracture. The main comparison will be made among the effects of three programs for preventing osteoporotic fractures: 1. health education; 2. exercise intervention for enhancing bone mineral density (BMD); 3. exercise intervention for preventing falls. The "cost" will be measured bases on the monetary cost of implementation of each program. The "effectiveness" will be measured includes the number of prevented osteoporotic fractures of each program, and related outcomes are the follows: 1. the medical cost of osteoporotic fracture; 2. the change of BMD in consecutive years; 3. the quality of life (QOL) of patients with osteoporotic fracture as compared to the reference population.
First year (2006): mainly a preparation stage
- To conduct a meta-analysis of the effects of various interventions of prevention of osteoporotic fracture, especially in exercise models.
- To establish the exercise programs for the intervention in the 2nd year, including the booklets and the posters.
- To review the other alternatives of prevention of osteoporotic fracture.
- To establish the social network needed for the following research. Second year (2007): to start the community-based field studies in Neihu District, Taipei.
All 37 "Lis" in Neihu will be invited to join the study, but only the Lis with willingness of participation will be the units for cluster sampling, and will be randomized to the three programs (Li as a unit). People living in the sampled Lis meet the inclusion criteria (postmenopausal (minimum for 1year) women and men over 65 years old) will be recruited and they will be further randomized into intervention group or reference group within each program.
1.To collect the baseline data. Baseline data include: the BMD, physical activity, nutrition diary, muscle strength, balance, risk factors of osteoporosis, history of fractures and falls 2.To execute the interventions. Three programs will be executed in the sampled Lis. They are all designed as a randomized control trial.
- Health education (HE trial): lectures on knowledge of osteoporosis, osteoporotic fracture, the risk factors, the nutritional demand, the exercise principles for enhancing BMD and preventing fall.
- Intervention for enhancing BMD (BMD trial): interventions to emphasize on weight-bearing exercise and trunk stabilization exercises. The exercise program will be supervised by a professional physical therapist 3 times per week for 3 months.
Intervention for preventing falls (fall prevention trial): interventions to emphasize on balance and strength training exercises. The exercise program will be also supervised by a professional physical therapist 3 times per week for 3 months.
3.To apply the NHRI released health insurance data (2002-2006) for the next year study Third year (2008): follow-up, cost calculation and study on medical cost
- To calculate the cost of three intervention programs (from the view of provider).
- Telephone follow-up (FU) and recording the incidence of fall & fracture every 3 months.
- The first FU (1st FU) of the items collected at baseline.
- To study the medical cost of osteoporotic fracture with NHRI data. Fourth year (2009): continuing follow-up and study on QOL
- Continuing the telephone FU and recording the incidence of fall & fracture every 3 months
- The second FU (2nd FU) of the items collected at baseline
- To conduct a survey for the health-related QOL of people with osteoporotic fracture from outpatient clinics in hospital and the newly fractured subjects in the community.
Fifth year (2010): continuing follow-up and CEA
- Continuing the telephone FU and recording the incidence of fall & fracture every 3 months.
- The third FU (3rd F/U) of the items collected at baseline.
- To investigate the effects of each intervention program
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taipei, Taiwan, 100
- National Taiwan University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- post menopausal women or male over 65 y/o
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Bone mineral density, osteoporotic fracture
|
Secondary Outcome Measures
Outcome Measure |
---|
CEA, Osteoporosis, Fracture, Prevention, Exercise
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9461700347
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoporosis or Osteopenia
-
MeddocThe Research Council of Norway; TineRecruitingOsteopenia or OsteoporosisNorway
-
Aarhus University HospitalCompleted
-
Umm Al-Qura UniversityCompletedOsteopenia or OsteoporosisSaudi Arabia
-
University of the AegeanCompletedOsteopenia or OsteoporosisGreece
-
Ohio UniversityUniversity of South Florida; University of Florida; Indiana University School...CompletedOsteoporosis | Osteoporosis Risk | Osteoporosis, Postmenopausal | Osteoporotic Fractures | Fragility Fracture | Bone Fracture | Osteopenia or OsteoporosisUnited States
-
Umm Al-Qura UniversityCompletedOsteopenia or OsteoprosisSaudi Arabia
-
University of Sao Paulo General HospitalCompletedOsteoporosis, Postmenopausal | Osteoporosis, OsteopeniaBrazil
-
Appalachian State UniversityNorth Carolina Agriculture & Technical State UniversityCompletedPostmenopausal Osteoporosis | Osteoporosis, OsteopeniaUnited States
-
Chinese PLA General HospitalBeijing Jishuitan Hospital; Beijing Aerospace General HospitalUnknownOsteoporosis | Osteopenia, OsteoporosisChina
-
NestléInstitut National de la Recherche Agronomique; Centre de Recherche en Nutrition...CompletedOsteoporosis, OsteopeniaFrance
Clinical Trials on exercise for strength, balance, health education
-
University of SaskatchewanSaskatchewan Health Research FoundationRecruiting
-
University of WaterlooCanadian Institutes of Health Research (CIHR); YMCA; City of Lakes family Health... and other collaboratorsCompletedCardiovascular Diseases | Stroke | Kidney Diseases | Hypertension | Diabetes Mellitus | Cancer | Arthritis | Chronic Disease | Chronic Lung Disease | Congestive Heart Failure | Osteoporosis, Osteopenia | FrailCanada
-
National University Health System, SingaporeNational University Hospital, Singapore; National Medical Research Council...CompletedDiabetic Neuropathies | Peripheral Nervous System DiseasesSingapore
-
Dilshaad Basrai VadRecruiting
-
The Arthritis Research Institute of AmericaCompletedKnee OsteoarthritisUnited States
-
University of ValenciaCompletedMental Health Disorder | LonelinessSpain
-
Federal University of PelotasRecruitingBreast Cancer FemaleBrazil
-
Teachers College, Columbia UniversityCompletedDepressive SymptomsUnited States
-
Central Taiwan University of Science and TechnologyCompletedDementia | Aging | Elderly | Physical DisabilityTaiwan
-
University Hospital, BordeauxUniversity of Bordeaux; Poitiers University Hospital; Centre National de la Recherche... and other collaboratorsCompletedAlzheimer's DiseaseFrance